C07C 215/58
With hydroxy groups and the six-membered aromatic ring, or the condensed ring
Official title: with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
C07C215/58 (With hydroxy groups and the six-membered aromatic ring, or the condensed ring) appears on 95 US grants and 106 published applications in this corpus.
Search patents in C07C- Granted patents
- 95
- Published applications
- 106
- Assignees
- 60
- Inventors
- 219
- Latest grant
- 10 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 5 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 5 | 5 |
| 2003 | 7 | 9 |
| 2004 | 6 | 10 |
| 2005 | 5 | 12 |
| 2006 | 4 | 3 |
| 2007 | 6 | 5 |
| 2008 | 4 | 7 |
| 2009 | 5 | 3 |
| 2010 | 3 | 5 |
| 2011 | 1 | 1 |
| 2012 | 1 | 4 |
| 2013 | 2 | 5 |
| 2014 | 4 | 3 |
| 2015 | 0 | 1 |
| 2016 | 2 | 5 |
| 2017 | 3 | 3 |
| 2018 | 4 | 5 |
| 2019 | 1 | 4 |
| 2020 | 2 | 5 |
| 2021 | 2 | 4 |
| 2022 | 4 | 2 |
| 2023 | 2 | 2 |
| 2024 | 1 | 0 |
| 2025 | 3 | 3 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Ligands for imaging cardiac innervation10 Jun 2025US 12,324,845 B2Lantheus Medical Imaging, Inc.
- Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia22 Apr 2025US 12,280,023 B2Atrogi AB
- Platform drug delivery system utilizing crystal engineering and theanine dissolution8 Apr 2025US 12,268,783 B2Theaprin Pharmaceuticals Inc.
- Crystalline epinephrine malonate salt5 Nov 2024US 12,134,588 B2Biothea Pharma, Inc.
- Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia24 Oct 2023US 11,793,774 B2Atrogi AB
- Platform drug delivery system utilizing crystal engineering and theanine dissolution17 Jul 2025US 2025/0228778 A1Theaprin Pharmaceuticals Inc.
- Ligands for imaging cardiac innervation22 May 2025US 2025/0161500 A1Lantheus Medical Imaging, Inc.
- Crystalline epinephrine malonate salt13 Feb 2025US 2025/0051262 A1Biothea Pharma, Inc.
- Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia16 Nov 2023US 2023/0364035 A1Atrogi AB
- Crystalline epinephrine malonate salt23 Mar 2023US 2023/0086578 A1Biothea Pharma, Inc.
Most cited
By later US patents
- Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist104US 5,460,605 AGensia, Inc. · 1995
- 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects90US 6,248,737 B1Gruenenthal GmbH · 2001
- Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist83US 5,286,252 AGensia Pharmaceuticals, Inc. · 1994
- Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist66US 5,108,363 AGensia Pharmaceuticals, Inc. · 1992
- Aryl aniline β2 adrenergic receptor agonists62US 6,670,376 B1Theravance, Inc. · 2003